Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn R Webster

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Postgraduate Medicine|December 20, 2014
Eight principles for safer opioid prescribing and cautions with benzodiazepinesLynn R Webster, Gary M Reisfield, Nabarun Dasgupta
Current Medical Research and Opinion|December 24, 2015
Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trialsBeatrice Setnik, Glenn C Pixton, Lynn R Webster
Journal of Opioid Management|October 1, 2011
Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough painLynn R Webster, John Messina, Fang Xie, et al.
Pain Medicine (Malden, Mass.)|April 4, 2017
A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer PainLynn R Webster, Tadaaki Yamada, Juan Camilo Arjona Ferreira
Advances in Therapy|September 26, 2020
A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory DriveLynn R Webster, Erik Hansen, Jacqueline Cater, et al.
Postgraduate Medicine|December 6, 2016
Current and future development of extended-release, abuse-deterrent opioid formulations in the United StatesLynn R Webster, John Markman, Edward J Cone, et al.
Pain Medicine (Malden, Mass.)|October 4, 2014
Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot studyLynn R Webster, Michael D Smith, Sam Mackin, et al.
Journal of Opioid Management|June 6, 2022
Drug trafficking, good faith, and legal standards to convict: How the United States Supreme Court is about to affect every prescriber in AmericaLynn R Webster, Ronald W Chapman Ii, Stephen J Ziegler
Journal of Pain Research|November 26, 2015
Low-dose naloxone provides an abuse-deterrent effect to buprenorphineLynn R Webster, Michael D Smith, Cemal Unal, et al.
Journal of Pain and Symptom Management|August 22, 2008
Long-term intrathecal ziconotide for chronic pain: an open-label studyLynn R Webster, Robert Fisher, Steven Charapata, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Postgraduate Medicine|December 20, 2014
Eight principles for safer opioid prescribing and cautions with benzodiazepinesLynn R Webster, Gary M Reisfield, Nabarun Dasgupta
Current Medical Research and Opinion|December 24, 2015
Safety profile of extended-release morphine sulfate with sequestered naltrexone hydrochloride in older patients: pooled analysis of three clinical trialsBeatrice Setnik, Glenn C Pixton, Lynn R Webster
Journal of Opioid Management|October 1, 2011
Effect of fentanyl buccal tablet on pain-related anxiety: a 4-week open-label study among opioid-tolerant patients with chronic and breakthrough painLynn R Webster, John Messina, Fang Xie, et al.
Pain Medicine (Malden, Mass.)|April 4, 2017
A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer PainLynn R Webster, Tadaaki Yamada, Juan Camilo Arjona Ferreira
Advances in Therapy|September 26, 2020
A Phase I Placebo-Controlled Trial Comparing the Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration on Respiratory DriveLynn R Webster, Erik Hansen, Jacqueline Cater, et al.
Postgraduate Medicine|December 6, 2016
Current and future development of extended-release, abuse-deterrent opioid formulations in the United StatesLynn R Webster, John Markman, Edward J Cone, et al.
Pain Medicine (Malden, Mass.)|October 4, 2014
Comparative effects of morning vs. evening dosing of extended-release hydromorphone on sleep physiology in patients with low back pain: a pilot studyLynn R Webster, Michael D Smith, Sam Mackin, et al.
Journal of Opioid Management|June 6, 2022
Drug trafficking, good faith, and legal standards to convict: How the United States Supreme Court is about to affect every prescriber in AmericaLynn R Webster, Ronald W Chapman Ii, Stephen J Ziegler
Journal of Pain Research|November 26, 2015
Low-dose naloxone provides an abuse-deterrent effect to buprenorphineLynn R Webster, Michael D Smith, Cemal Unal, et al.
Journal of Pain and Symptom Management|August 22, 2008
Long-term intrathecal ziconotide for chronic pain: an open-label studyLynn R Webster, Robert Fisher, Steven Charapata, et al.
Pageof 14